PARP inhibition causes replication stress in preclinical models of high risk neuroblastoma and synergises with inhibition of ATR

被引：0
|
作者：
Southgate, Harriet [1 ]
Curtin, Nicola J. [1 ]
Tweddle, Deborah A. [1 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF CANCER | 2019年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
57
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] Combined inhibition of AXL and ATR enhances replication stress, cell death and immune response in small cell lung cancer
    Ramkumar, Kavya
    Stewart, C. Allison
    Tanimoto, Azusa
    Wang, Qi
    Xi, Yuanxin
    Morris, Benjamin B.
    Wang, Runsheng
    Shen, Li
    Cardnell, Robert J.
    Wang, Jing
    Gay, Carl M.
    Byers, Lauren A.
    CANCER RESEARCH, 2023, 83 (07)
  • [42] Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models
    Kim, Hyoung
    George, Erin
    Ragland, Ryan L.
    Rafail, Stavros
    Zhang, Rugang
    Krepler, Clemens
    Morgan, Mark A.
    Herlyn, Meenhard
    Brown, Eric J.
    Simpkins, Fiona
    CLINICAL CANCER RESEARCH, 2017, 23 (12) : 3097 - 3108
  • [43] Durable inhibition of hepatitis B virus replication and antigenemia using a subcutaneously administered siRNA agent in preclinical models
    Lee, A. C. H.
    Heyes, J.
    Ye, X.
    Holland, R.
    Thi, E. P.
    Wood, M.
    Judge, A.
    Snead, N. M.
    Martin, A.
    Sofia, M. J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S18 - S18
  • [44] Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models
    Hong, Xiaodan
    Cai, Zuhuan
    Zhou, Fang
    Jin, Xiaoliang
    Wang, Guangji
    Ouyang, Bingchen
    Zhang, Jingwei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [45] INHIBITION OF ATM KINASE BY THE CNS-PENETRANT AZD1390 ENHANCED RADIOTHERAPY IN NEUROBLASTOMA AND RHABDOMYOSARCOMA PRECLINICAL MODELS
    Burrow, Trevor
    Graham, Kevin
    Koneru, Balakrishna
    Farooqi, Ahsan
    Houghton, Peter
    Dela Cruz, Filemon
    Kalapurakal, John
    Reynolds, C. Patrick
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S69 - S69
  • [46] Inhibition of epigenetic regulator menin is a novel therapeutic approach for high-risk neuroblastoma
    Chilamakuri, Rameswari
    Agarwal, Saurabh
    CANCER RESEARCH, 2022, 82 (12)
  • [47] FGFR2 modulates ALK inhibition response in high-risk neuroblastoma
    Pucci, Perla
    Barrett, Charlotte
    Trigg, Ricky
    Jahangiri, Leila
    Matthews, Jamie D.
    Mologni, Luca
    Burke, G. A. Amos
    Turner, Suzanne D.
    CANCER RESEARCH, 2023, 83 (08)
  • [48] Experimental glioma with high bHLH expression harbor increased replicative stress and are sensitive toward ATR inhibition
    Koch, Marlin Sophia
    Czemmel, Stefan
    Lennartz, Felix
    Beyeler, Sarah
    Rajaraman, Srinath
    Przystal, Justyna Magdalena
    Govindarajan, Parameswari
    Canjuga, Denis
    Neumann, Manfred
    Rizzu, Patrizia
    Zwirner, Stefan
    Hoetker, Michael Stefan
    Zender, Lars
    Walter, Bianca
    Tatagiba, Marcos
    Raineteau, Olivier
    Heutink, Peter
    Nahnsen, Sven
    Tabatabai, Ghazaleh
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [49] SF3B1 hotspot mutations confer sensitivity to PARP inhibition through a defective replication stress response
    Bland, Philip
    Saville, Harry
    Wai, Patty T.
    Curnow, Lucinda
    Nieminuszczy, Jadwiga
    Ravindran, Nivedita
    Barker, Holly E.
    Wright, James
    Yu, Lu
    Mavrommati, Ioanna
    Peck, Barrie
    Gazinska, Patrycja
    Pemberton, Helen N.
    Gulati, Aditi
    Guppy, Naomi
    Roxanis, Ioannis
    Pratt, Guy
    Oldreive, Ceri
    Stankovic, Tatjana
    Barlow, Samantha
    Kalirai, Helen
    Coupland, Sarah E.
    Broderick, Ronan
    Alsafadi, Samar
    Houy, Alexandre
    Stern, Marc-Henri
    Pettit, Stephen
    Choudhary, Jyoti S.
    Haider, Syed
    Niedzwiedz, Wojciech
    Lord, Christopher J.
    Natrajan, Rachael
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [50] SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response
    Bland, Philip
    Saville, Harry
    Wai, Patty T.
    Curnow, Lucinda
    Muirhead, Gareth
    Nieminuszczy, Jadwiga
    Ravindran, Nivedita
    John, Marie Beatrix
    Hedayat, Somaieh
    Barker, Holly E.
    Wright, James
    Yu, Lu
    Mavrommati, Ioanna
    Read, Abigail
    Peck, Barrie
    Allen, Mark
    Gazinska, Patrycja
    Pemberton, Helen N.
    Gulati, Aditi
    Nash, Sarah
    Noor, Farzana
    Guppy, Naomi
    Roxanis, Ioannis
    Pratt, Guy
    Oldreive, Ceri
    Stankovic, Tatjana
    Barlow, Samantha
    Kalirai, Helen
    Coupland, Sarah E.
    Broderick, Ronan
    Alsafadi, Samar
    Houy, Alexandre
    Stern, Marc-Henri
    Pettit, Stephen
    Choudhary, Jyoti S.
    Haider, Syed
    Niedzwiedz, Wojciech
    Lord, Christopher J.
    Natrajan, Rachael
    NATURE GENETICS, 2023, 55 (08) : 1311 - +
12345